4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-187.24%
↑ 100% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-55043.56%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -187.24% | +100.0% |
| 2024 | -489556.76% | -93262.8% |
| 2023 | -524.36% | +84.8% |
| 2022 | -3439.73% | -788.8% |
| 2021 | -387.02% | +4.6% |
| 2020 | -405.68% | +36.5% |
| 2019 | -638.75% | -830.3% |
| 2018 | -68.66% | +62.7% |
| 2017 | -183.87% | - |